News Conference News EuroPCR 2025 PREDICT Offers a Heads-up on the Need for CT in Suspected Small Aortic Annuli L.A. McKeown May 23, 2025
News Conference News EuroPCR 2024 Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY Michael O'Riordan May 17, 2024
News Conference News EuroPCR 2024 Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter? Shelley Wood May 15, 2024
News Conference News EuroPCR 2024 Debate Continues on TAVI Choice for Women With Small Annuli Yael L. Maxwell May 14, 2024
News Conference News EuroPCR 2022 Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN Caitlin E. Cox May 27, 2022
News Conference News EuroPCR 2022 Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes Caitlin E. Cox May 17, 2022
News Conference News EuroPCR 2021 Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI Yael L. Maxwell May 19, 2021
News Conference News EuroPCR 2020 ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead Yael L. Maxwell July 03, 2020
News Conference News EuroPCR 2019 TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement Shelley Wood May 23, 2019
News Conference News EuroPCR 2018 NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years Caitlin E. Cox May 24, 2018
Presentation EuroPCR 2017 Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI Presenter: Luca Testa May 19, 2017
News Conference News EuroPCR 2017 More Early Stroke With SAVR Than TAVR in SURTAVI Shelley Wood May 18, 2017
News Conference News EuroPCR 2017 TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years Caitlin E. Cox May 17, 2017
News Conference News EuroPCR 2017 REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial Shelley Wood May 16, 2017